Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial Cohen, A. T., Halaby, R., Korjian, S., Daaboul, Y., Szlosek, D., Arbetter, D., Goldhaber, S. Z., Hull, R., Hernandez, A., Gold, A., Wiens, B., Harrington, R., Gibson, C. AMER SOC HEMATOLOGY. 2016
View details for DOI 10.1182/blood.V128.22.3824.3824
View details for Web of Science ID 000394452302017